Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Centamin Plc Board/Management Information 2021

Dec 21, 2021

6270_mang_2021-12-21_425b9fc6-9ae3-4035-8914-5d1bedaf71a5.html

Board/Management Information

Open in viewer

Opens in your device viewer

{# SEO P0-1: filing HTML is rendered server-side so Googlebot sees the full text without executing JS or following an iframe to a Disallow'd CDN path. The content has already been sanitized through filings.seo.sanitize_filing_html. #}

National Storage Mechanism | Additional information

RNS Number : 2648W

Centamin PLC

21 December 2021

21 December 2021

Centamin plc

("Centamin" or "the Company" or "Group", including its subsidiaries)

LSE: CEY / TSX: CEE

director declaration

In accordance with Listing Rule 9.6.14, the Company announces that Dr Catharine Farrow, Non-Executive Director of Centamin, has been appointed as a non-executive director of Aclara Resources, listed on the Toronto Stock Exchange.

Further to Centamin and Alcara Resources, Catharine is a non-executive director of Franco-Nevada Corporate and Eldorado Gold Corporation.

This announcement contains ongoing regulated information.

FOR MORE INFORMATION please visit the website www.centamin.com or contact:

Centamin plc

Alexandra Barter-Carse, Corporate Communications

+44 (0) 7700 713 738

[email protected]
Buchanan

Bobby Morse/ Ariadna Peretz/ James Husband

+ 44 (0) 20 7466 5000

[email protected]

LEI: 213800PDI9G7OUKLPV84

Company No: 109180

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

RDNFEEFWSEFSEIE